OmniaBio
Company Information
OmniaBio is a Hamilton-based contract development and manufacturing organization focused on cell and gene therapy. The company’s website emphasizes process development, analytical development, GMP manufacturing, autologous manufacturing, cell banking, regulatory guidance, and commercial-scale production. Its platform expertise specifically references immune cell therapies, lentiviral vector workflows, and iPSC-based programs supported by advanced automation and AI-enabled manufacturing.
Industry Focus and Technologies
Cell and gene therapy CDMO, GMP manufacturing, process development, analytical development, immunotherapy, lentiviral vectors, iPSC platforms, autologous manufacturing, and cell banking.
Location
Hamilton, Ontario, Canada
Company Size and Stage
Products, Platforms or Focus Areas
Cell and gene therapy development and manufacturing services, autologous cell therapy manufacturing, lentiviral vector support, iPSC-based program support, analytical development, cell banking, and commercial-scale GMP production.